Support and grants

The executive secretariat of the HPV prevention and Control Board benefits from being seated at the Center for the Evaluation of Vaccination (CEV) of the University of Antwerp, where it has the infrastructure and administrative services of the University at its disposal.

The HPV Prevention and Control is supported by unrestricted grants from the vaccine industry (GlaxoSmithKline Biologicals, Merck, Abbott, Sanofi Pasteur and MSD), several universities in Europe and other institutions.

For the HPV Prevention and Control Board and its advisors strict operational and scientific independence is essential. HPV Prevention and Control Board advisers and invited experts get only travel and subsistence reimbursed according to the University Rules, no honorary or other forms of remuneration are provided.

The HPV prevention and Control Board does accept unrestricted grants from companies to support their activities including web development but maintains all editorial control over the content of the site. Editorial control of the site rests entirely with the secretariat of the HPV Prevention and Control Board.

Last update

Last updated on 08/12/2017